BrainChip Secures Initial Commercial Batch of 2,000 AKD1500 Neuromorphic Processors, Targets H2 2026 Shipments

AKD1500 Production Milestone and Manufacturing Readiness

Receiving the first production batch of 2,000 AKD1500 neuromorphic processors during the June 2026 quarter marks a pivotal operational milestone for BrainChip. This initial manufacturing run signifies the company’s formal transition from pre-production evaluation to commercial-scale manufacturing, confirming readiness in manufacturing and supply chain for customer deployment. These units are intended to support commercial shipments starting in the second half of 2026 across defence, industrial, infrastructure, and edge AI applications.

Additional AKD1500 shipments will continue through Q3 until the full production run of approximately 60,000 units is delivered. However, the total volume is slightly below initial expectations due to lower production yields. BrainChip is analyzing production data to identify the cause of this variance, an important factor for investors monitoring the company’s path to volume production and revenue generation.

Strategic IP Licensing and Akida 2.0 Contractual Delivery

During the June quarter, BrainChip delivered RTL design assets to EDGEAI under the Akida 2.0 licensing agreement. This delivery is a key contractual milestone enabling EDGEAI to integrate BrainChip’s neuromorphic technology into custom silicon solutions for advanced smart metering and infrastructure applications. This achievement underscores BrainChip’s capability to execute commercial IP licensing agreements and establish future royalty streams.

The Akida 2.0 licensing agreement exemplifies BrainChip’s strategy to generate recurring revenue through strategic licensing beyond direct processor sales. By empowering licensees like EDGEAI to develop custom silicon with BrainChip’s neuromorphic architecture, the company expands its revenue channels and market reach. This approach allows partners to create application-specific solutions while BrainChip benefits from royalties and ecosystem growth.

LDA Put Option Agreement Expiration and Share Settlement

The LDA Capital Put Option Agreement expired on 30 June 2026, as announced on 24 July 2026. The $1.0 million Failure Fee was satisfied through liquidation of collateral shares held by LDA under the agreement. Approximately 6.96 million BrainChip shares were sold, generating gross proceeds of about A$1.0 million, fully applied to the Failure Fee. This transaction resolved the company’s obligations related to the fee and concluded the associated commercial arrangements.

After this sale, about 6.0 million collateral shares remained with LDA, which intends to sell these shares orderly over the following weeks. Net proceeds from these sales, after deducting LDA’s 8.5% contractual fee and other payable amounts, will be remitted to BrainChip. The expiration of the Put Option Agreement ended the financing facility’s availability and substantially completed the settlement of obligations between the parties. BrainChip will provide further updates upon completion of the remaining collateral share disposals and receipt of net proceeds.

Planned Hardware Enablement Platforms for Customer Adoption

To accelerate customer evaluation, prototyping, and commercial adoption of the AKD1500 processor, BrainChip plans to allocate over 2,000 AKD1500 units to develop multiple hardware form factors during H2 2026. These platforms aim to reduce integration timelines and provide customers with immediate access to production silicon in familiar development environments. This initiative supports diverse customer engagements across industrial, communications, defence, infrastructure, and edge AI sectors.

Hardware offerings will include M.2 accelerator modules, PCIe accelerator cards, Raspberry Pi 4 and 5 development boards, and BrainChip’s application-focused reference platforms such as AkidaTag®, Akida Radar, and Akida EW. These options facilitate rapid proof-of-concept development, advanced application evaluation, and system integration. By offering AKD1500 in multiple hardware configurations, BrainChip expects to lower adoption barriers and enable customers to assess performance, power efficiency, and scalability within their environments. Management views this hardware enablement investment as a key commercialisation driver.

Software Development and Customer Integration Pathway

Production-ready development platforms enable customers to start software development, algorithm validation, and system testing immediately, shortening the timeline from engagement to deployment. These hardware platforms support existing programs and serve as evaluation systems for new opportunities across BrainChip’s expanding ecosystem of partners, licensees, and end-users. Allocating production units to hardware platforms reflects management’s belief that accelerating customer adoption is critical for near-term revenue growth.

BrainChip’s parallel development of multiple form factors—from rapid development boards to production accelerator cards—addresses diverse technical and integration needs across customer segments and applications. By providing turnkey solutions that minimize engineering effort and speed deployment, BrainChip aims to capture a larger share of market opportunities and build strong customer relationships early in the adoption cycle.

AKD2500 Advancement and Next-Generation Development

BrainChip continued progress on the AKD2500 during the June 2026 quarter, maintaining schedule for an early December 2026 tapeout. The AKD2500 is the company’s next-generation neuromorphic processor and a critical part of its long-term technology roadmap. Progress on this project indicates effective management of the product development pipeline despite the AKD1500 production yield challenges.

Developing successive processor generations is vital for BrainChip’s competitiveness in the AI semiconductor market. By advancing the AKD2500 alongside commercialising the AKD1500, BrainChip offers customers a path to new technology while maximizing near-term revenue from current production. The early December tapeout target suggests transition from design validation to silicon manufacturing initiation within two quarters.

Generative AI Platform Development and Expected Demonstrations

BrainChip made steady progress on its Generative AI (GenAI) program during the quarter, achieving key milestones in model development and software infrastructure. Development remains on schedule, with internal GenAI platform demonstrations expected in late Q3 2026. This program aims to showcase ultra-efficient AI inference and advanced edge intelligence using neuromorphic computing principles.

The GenAI initiative expands BrainChip’s technology scope beyond traditional signal processing and edge AI to broader generative AI applications. Successful demonstrations could unlock significant new markets in edge computing, mobile devices, and IoT. Management anticipates tangible proof-of-concept results for partners, customers, and investors within the current fiscal year.

Defence-Focused AI Model Development and Radar Applications

Alongside GenAI, BrainChip is developing four core AI models targeting radar and electronic warfare applications. These models support defence and signal intelligence use cases such as signal classification, threat detection, object identification, and spectrum awareness at the edge. This effort builds on the company’s Radar Reference Platform and Electronic Warfare initiatives, demonstrating neuromorphic computing’s relevance in mission-critical environments.

Focusing on defence-specific AI models positions BrainChip in high-value, regulated markets where ultra-low-power AI inference offers operational advantages. Defence and signal intelligence applications require reliable performance in power-constrained settings, making neuromorphic computing highly suitable. Developing application-specific models for radar and electronic warfare reflects BrainChip’s commitment to delivering tailored solutions rather than generic AI processors.

Software Stack Development and Tool Advancement

Software stack development progressed on schedule in the June quarter, focusing on enhancing model deployment tools, workflows, and runtime capabilities. Maturing BrainChip’s software ecosystem is critical for customer adoption, as developers need intuitive tools and clear processes to integrate neuromorphic processors efficiently. Progress indicates coordinated advancement of hardware and software development.

Developing robust deployment tools is essential given the specialized nature of neuromorphic computing and many developers’ unfamiliarity with its programming paradigms. By investing in software infrastructure and developer tools, BrainChip aims to lower technical barriers and accelerate time-to-production. This software effort complements hardware enablement initiatives, reflecting a comprehensive customer enablement strategy across silicon and software.

Cash Position and Financial Runway

BrainChip ended the June 2026 quarter with $20.3 million in cash, providing liquidity to fund operations and development through 2026. This cash position reflects the company’s burn rate and capacity to continue executing its commercialisation strategy, hardware platform development, and advanced AI programs without immediate external funding. Investors will monitor cash consumption relative to progress toward commercial revenue.

The cash balance must be considered alongside expected operational expenses for product development, customer engagement, and production support through H2 2026. While detailed burn projections were not disclosed, $20.3 million provides a financial foundation for anticipated commercial shipments and deployment support. The timing of commercial revenue recognition will be critical in determining if additional financing is needed before reaching cash flow breakeven.